Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mycobacterium tuberculosis | 13 | 2024 | 1912 | 0.800 |
Why?
|
Mycobacterium smegmatis | 1 | 2017 | 126 | 0.530 |
Why?
|
Ribosomes | 1 | 2017 | 494 | 0.440 |
Why?
|
Drug Resistance, Bacterial | 2 | 2017 | 1048 | 0.350 |
Why?
|
Antitubercular Agents | 4 | 2019 | 1374 | 0.270 |
Why?
|
Genome, Bacterial | 4 | 2023 | 785 | 0.270 |
Why?
|
Host-Pathogen Interactions | 2 | 2021 | 1448 | 0.230 |
Why?
|
Tuberculosis | 6 | 2023 | 2016 | 0.220 |
Why?
|
Microbial Sensitivity Tests | 4 | 2019 | 1936 | 0.210 |
Why?
|
Phagosomes | 1 | 2003 | 199 | 0.200 |
Why?
|
Drug Resistance, Multiple, Bacterial | 2 | 2017 | 585 | 0.200 |
Why?
|
Bacteria | 2 | 2012 | 2190 | 0.180 |
Why?
|
Small Molecule Libraries | 2 | 2019 | 731 | 0.170 |
Why?
|
Gene Expression Regulation, Bacterial | 3 | 2017 | 1131 | 0.170 |
Why?
|
DNA Gyrase | 2 | 2019 | 85 | 0.170 |
Why?
|
Blood Donors | 1 | 2021 | 345 | 0.160 |
Why?
|
Bacterial Proteins | 4 | 2018 | 3836 | 0.150 |
Why?
|
Coumarins | 1 | 2018 | 118 | 0.150 |
Why?
|
Mutation | 4 | 2017 | 30002 | 0.140 |
Why?
|
Ofloxacin | 1 | 2016 | 66 | 0.140 |
Why?
|
beta-Lactam Resistance | 1 | 2015 | 73 | 0.120 |
Why?
|
Penicillin-Binding Proteins | 1 | 2015 | 149 | 0.120 |
Why?
|
beta-Lactams | 1 | 2015 | 156 | 0.110 |
Why?
|
Antibodies, Viral | 2 | 2023 | 3149 | 0.110 |
Why?
|
Drug Resistance, Microbial | 3 | 2019 | 826 | 0.110 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2017 | 3777 | 0.100 |
Why?
|
Tuberculosis, Multidrug-Resistant | 2 | 2017 | 934 | 0.100 |
Why?
|
Gene Deletion | 1 | 2019 | 2658 | 0.100 |
Why?
|
Microfluidics | 1 | 2017 | 651 | 0.100 |
Why?
|
Drug Discovery | 1 | 2019 | 1050 | 0.090 |
Why?
|
Gene Expression Profiling | 3 | 2017 | 9416 | 0.090 |
Why?
|
DNA, Bacterial | 2 | 2023 | 1470 | 0.090 |
Why?
|
High-Throughput Screening Assays | 1 | 2017 | 931 | 0.090 |
Why?
|
Gene Duplication | 1 | 2012 | 314 | 0.090 |
Why?
|
Urine | 1 | 2012 | 362 | 0.090 |
Why?
|
Genomics | 3 | 2017 | 5828 | 0.090 |
Why?
|
Myocardium | 1 | 2021 | 4746 | 0.080 |
Why?
|
Lung | 3 | 2021 | 9979 | 0.070 |
Why?
|
Bacterial Infections | 2 | 2017 | 1390 | 0.070 |
Why?
|
Virulence Factors | 1 | 2011 | 511 | 0.070 |
Why?
|
Proteome | 1 | 2017 | 1856 | 0.070 |
Why?
|
Kidney | 1 | 2021 | 7033 | 0.060 |
Why?
|
Liver | 1 | 2021 | 7514 | 0.060 |
Why?
|
Polymorphism, Genetic | 2 | 2017 | 4243 | 0.050 |
Why?
|
Cell-Free System | 1 | 2023 | 336 | 0.050 |
Why?
|
Antibodies, Neutralizing | 2 | 2023 | 1935 | 0.050 |
Why?
|
RNA | 1 | 2012 | 2709 | 0.050 |
Why?
|
Disease Models, Animal | 3 | 2018 | 18220 | 0.050 |
Why?
|
Structure-Activity Relationship | 2 | 2018 | 3057 | 0.050 |
Why?
|
Lipase | 1 | 2024 | 320 | 0.050 |
Why?
|
Host-Parasite Interactions | 1 | 2003 | 300 | 0.050 |
Why?
|
Neutralization Tests | 1 | 2023 | 725 | 0.050 |
Why?
|
Carbon | 1 | 2024 | 665 | 0.040 |
Why?
|
Anti-Bacterial Agents | 2 | 2024 | 7407 | 0.040 |
Why?
|
Seroepidemiologic Studies | 1 | 2021 | 399 | 0.040 |
Why?
|
Atlases as Topic | 1 | 2021 | 247 | 0.040 |
Why?
|
Mycolic Acids | 1 | 2019 | 54 | 0.040 |
Why?
|
Promoter Regions, Genetic | 1 | 2011 | 5773 | 0.040 |
Why?
|
Phagocytes | 1 | 2021 | 294 | 0.040 |
Why?
|
Serologic Tests | 1 | 2021 | 381 | 0.040 |
Why?
|
Topoisomerase II Inhibitors | 1 | 2019 | 94 | 0.040 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2003 | 2477 | 0.040 |
Why?
|
Immunity, Humoral | 1 | 2023 | 598 | 0.040 |
Why?
|
Pulmonary Alveoli | 1 | 2021 | 651 | 0.040 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2004 | 830 | 0.040 |
Why?
|
Autopsy | 1 | 2021 | 1010 | 0.040 |
Why?
|
Tryptophan | 1 | 2019 | 480 | 0.040 |
Why?
|
Genetic Variation | 1 | 2012 | 6567 | 0.030 |
Why?
|
Soil Microbiology | 1 | 2017 | 88 | 0.030 |
Why?
|
Catalase | 1 | 2017 | 217 | 0.030 |
Why?
|
Organ Specificity | 1 | 2021 | 1963 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2004 | 3155 | 0.030 |
Why?
|
Fatty Acids | 1 | 2024 | 1807 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2003 | 2138 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 2021 | 780 | 0.030 |
Why?
|
Isoniazid | 1 | 2017 | 283 | 0.030 |
Why?
|
Substrate Specificity | 1 | 2019 | 1768 | 0.030 |
Why?
|
Rifampin | 1 | 2017 | 338 | 0.030 |
Why?
|
Forecasting | 1 | 2004 | 2928 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2017 | 3634 | 0.030 |
Why?
|
Gene Library | 1 | 2017 | 1054 | 0.030 |
Why?
|
Pneumonia, Bacterial | 1 | 2016 | 316 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 1331 | 0.030 |
Why?
|
Mutagenesis, Insertional | 1 | 2015 | 657 | 0.030 |
Why?
|
Clone Cells | 1 | 2016 | 1668 | 0.030 |
Why?
|
Quinolines | 1 | 2018 | 764 | 0.030 |
Why?
|
RNA, Viral | 1 | 2021 | 2839 | 0.030 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2017 | 432 | 0.030 |
Why?
|
Folic Acid | 1 | 2019 | 1323 | 0.030 |
Why?
|
Chronic Disease | 2 | 2005 | 9319 | 0.020 |
Why?
|
Regeneration | 1 | 2021 | 1505 | 0.020 |
Why?
|
Selection, Genetic | 1 | 2016 | 871 | 0.020 |
Why?
|
Viral Load | 1 | 2021 | 3328 | 0.020 |
Why?
|
Animals | 5 | 2018 | 168079 | 0.020 |
Why?
|
Humans | 12 | 2024 | 761208 | 0.020 |
Why?
|
Herpesvirus 2, Human | 1 | 2012 | 191 | 0.020 |
Why?
|
Fibroblasts | 1 | 2021 | 4137 | 0.020 |
Why?
|
Environmental Monitoring | 1 | 2017 | 1460 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2451 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2021 | 4537 | 0.020 |
Why?
|
Fungi | 1 | 2012 | 337 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2021 | 3671 | 0.020 |
Why?
|
Pseudomonas aeruginosa | 1 | 2017 | 1272 | 0.020 |
Why?
|
Phylogeny | 1 | 2016 | 2809 | 0.020 |
Why?
|
Macrophages | 1 | 2003 | 5753 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2021 | 3551 | 0.020 |
Why?
|
Evolution, Molecular | 1 | 2016 | 1882 | 0.020 |
Why?
|
Heart | 1 | 2021 | 4431 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2019 | 20119 | 0.020 |
Why?
|
Databases, Nucleic Acid | 1 | 2008 | 205 | 0.020 |
Why?
|
Species Specificity | 1 | 2012 | 2406 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2019 | 2813 | 0.020 |
Why?
|
Herpesvirus 1, Human | 1 | 2012 | 739 | 0.020 |
Why?
|
HeLa Cells | 1 | 2012 | 3073 | 0.020 |
Why?
|
Colony Count, Microbial | 1 | 2005 | 328 | 0.010 |
Why?
|
Chromosomes, Bacterial | 1 | 2005 | 280 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15841 | 0.010 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2004 | 517 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2012 | 4243 | 0.010 |
Why?
|
Erythrocytes | 1 | 2012 | 2413 | 0.010 |
Why?
|
Plasmodium falciparum | 1 | 2012 | 1740 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 12676 | 0.010 |
Why?
|
Nitric Oxide Synthase | 1 | 2004 | 908 | 0.010 |
Why?
|
Inflammation | 1 | 2021 | 10759 | 0.010 |
Why?
|
DNA Transposable Elements | 1 | 2004 | 754 | 0.010 |
Why?
|
Mutagenesis | 1 | 2004 | 1226 | 0.010 |
Why?
|
Mice | 3 | 2018 | 81326 | 0.010 |
Why?
|
Base Sequence | 1 | 2008 | 12404 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2017 | 15920 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2012 | 18926 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 2005 | 22127 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2021 | 58952 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 14675 | 0.010 |
Why?
|
Aged | 1 | 2021 | 169288 | 0.000 |
Why?
|
Algorithms | 1 | 2008 | 14025 | 0.000 |
Why?
|
Male | 2 | 2021 | 360693 | 0.000 |
Why?
|
Middle Aged | 1 | 2021 | 220853 | 0.000 |
Why?
|
Adult | 1 | 2021 | 221119 | 0.000 |
Why?
|
Female | 2 | 2021 | 392544 | 0.000 |
Why?
|
Concepts
(139)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(44)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_